The economic burden of bipolar disorder in the United States: a systematic literature review

L Bessonova, K Ogden, MJ Doane… - ClinicoEconomics …, 2020 - Taylor & Francis
Bipolar disorder (BD) is a mood disorder with subtypes characterized by episodes of mania,
hypomania, and/or depression. BD is associated with substantial economic burden, and the …

Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses

U McCormick, B Murray, B McNew - Journal of the American …, 2015 - journals.lww.com
Purpose: This review article provides an overview of the frequency, burden of illness,
diagnosis, and treatment of bipolar disorder (BD) from the perspective of the advanced …

[HTML][HTML] Treatment-adherence in bipolar disorder: a patient-centred approach

S Chakrabarti - World journal of psychiatry, 2016 - ncbi.nlm.nih.gov
About half of the patients diagnosed with bipolar disorder (BD) become non-adherent during
long-term treatment, a rate largely similar to other chronic illnesses and one that has …

Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression

M Tohen, DP McDonnell, M Case, S Kanba… - The British Journal of …, 2012 - cambridge.org
BackgroundAtypical antipsychotics are widely used in bipolar mania. However, the efficacy
of atypical antipsychotics in bipolar depression has not been comprehensively explored …

[HTML][HTML] Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments

MW Jann - American health & drug benefits, 2014 - ncbi.nlm.nih.gov
Background Patients with bipolar disorder are exceptionally challenging to manage
because of the dynamic, chronic, and fluctuating nature of their disease. Typically, the …

A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

E Vieta, S Montgomery, AH Sulaiman… - European …, 2012 - Elsevier
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …

Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA

M Greene, L Paladini, T Lemmer… - Neuropsychiatric …, 2018 - Taylor & Francis
Background Bipolar disorder type I (BD-I) is a chronic condition characterized by mania
episodes followed by syndromic recovery periods, usually permeated by depressive …

Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization

Y Jiang, W Ni - … : The Journal of Human Pharmacology and …, 2015 - Wiley Online Library
Study Objective To estimate the impact of adherence to and persistence with atypical
antipsychotics on health care costs and risk of hospitalization by controlling potential …

Effect of long acting injectable antipsychotics on course and hospitalizations in bipolar disorder–a naturalistic mirror image study

E Yıldızhan, E Uzun, NB Tomruk - Nordic Journal of Psychiatry, 2022 - Taylor & Francis
Purpose To determining whether the addition of a long-acting injectable antipsychotic (LAI-
AP) has a positive effect on prognosis in bipolar disorder. Materials and methods Medical …

Reduction of healthcare costs through a transitions-of-care program

W Ni, D Colayco, J Hashimoto, K Komoto… - The Bulletin of the …, 2018 - academic.oup.com
Purpose Results of an evaluation of the impact of a pharmacy-based transitional care
program on healthcare costs in a population of high-risk patients are reported. Methods A …